The University of Chicago Header Logo

Connection

Ezra Cohen to Cyclooxygenase 2 Inhibitors

Back to Details
This is a "connection" page, showing publications Ezra Cohen has written about Cyclooxygenase 2 Inhibitors.
Ezra Cohen
Connection Strength
0.059
Cyclooxygenase 2 Inhibitors
  1. Genome-wide CRISPR Screening Reveals a PKA-Driven Resistance Mechanism to Metformin for Oral Cancer Prevention That Can Be Exploited by Combination with NSAIDs. Cancer Prev Res (Phila). 2026 02 06; 19(2):79-92.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.